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Introduction
DNA double-strand breaks (DSBs) represent biologically impor-
tant lesions because incorrectly repaired DSBs can lead to translo-
cations and other genomic rearrangements, driving forces during 
carcinogenesis (van Gent et al., 2001; Jackson and Bartek, 2009; 
Bunting and Nussenzweig, 2013; Panier and Durocher, 2013). 
Two major DSB repair pathways exist, canonical nonhomolo-
gous end-joining (NHEJ; c-NHEJ) and homologous recombina-
tion (HR; Lukas et al., 2011b; Polo and Jackson, 2011; Chapman 
et al., 2012; Davis and Chen, 2013). NHEJ repairs the majority of 
ionizing radiation (IR)–induced DSBs and functions throughout 
the cell cycle (Rothkamm et al., 2003; van Gent and van der Burg, 
2007). In contrast to NHEJ, HR is restricted to the S and G2 phases 
of the cell cycle, in which homologous sequences on the sister 
chromatid serve as a template for repair (Moynahan and Jasin, 
2010). HR is initiated by C terminal binding protein–interacting 
protein (CtIP)–dependent resection to create 3 overhangs at 
the DSB ends (Sartori et al., 2007). DSB repair can also occur 
by an alternative NHEJ mechanism, termed alt-NHEJ (Wang 
et al., 2005, 2006; Nussenzweig and Nussenzweig, 2007).
In addition to its role in promoting resection during HR, 
increasing evidence suggests that CtIP can also function during 
NHEJ. CtIP-dependent microhomology-mediated NHEJ oc-
curs in wild-type (wt) chicken cells (Yun and Hiom, 2009), and 
short single-stranded DNA regions exposed by CtIP-dependent 
resection facilitate rejoining during class switch recombination 
in mammalian cells (Lee-Theilen et al., 2011). Moreover, a 
CtIP-dependent process exposes microhomologies and causes 
 DNA double-strand breaks (DSBs) are repaired by nonhomologous end joining (NHEJ) or homolo-gous recombination (HR). The C terminal binding 
protein–interacting protein (CtIP) is phosphorylated in G2 
by cyclin-dependent kinases to initiate resection and pro-
mote HR. CtIP also exerts functions during NHEJ, although 
the mechanism phosphorylating CtIP in G1 is unknown. In 
this paper, we identify Plk3 (Polo-like kinase 3) as a novel 
DSB response factor that phosphorylates CtIP in G1 in a 
damage-inducible manner and impacts on various cellu-
lar processes in G1. First, Plk3 and CtIP enhance the 
formation of ionizing radiation-induced translocations; 
second, they promote large-scale genomic deletions from 
restriction enzyme-induced DSBs; third, they are required 
for resection and repair of complex DSBs; and finally, 
they regulate alternative NHEJ processes in Ku/ mu-
tants. We show that mutating CtIP at S327 or T847 to 
nonphosphorylatable alanine phenocopies Plk3 or CtIP 
loss. Plk3 binds to CtIP phosphorylated at S327 via its 
Polo box domains, which is necessary for robust damage-
induced CtIP phosphorylation at S327 and subsequent 
CtIP phosphorylation at T847.
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was plotted against the DAPI signal, and G1 cells were dis-
criminated from G2 cells based on their DNA content and from 
S-phase cells by the absence of EdU (Fig. 1 a, right). Control 
experiments confirmed that all cells identified as G1 were nega-
tive for the S/G2 marker CENP-F (Fig. 1 a, left). Cells identified 
as G1 cells were marked in the histogram and automatically 
relocated for manual foci enumeration (Fig. 1 a). The addition 
of nocodazole prevented G2-irradiated cells from progressing 
into G1 during repair incubation. Therefore, the identified G1 
cells were irradiated in G1 and maintained in G1 during the 
entire repair period. Thus, this EdU-based approach allows us 
to measure cell cycle–specific DSB repair kinetics and avoids 
the usage of aphidicolin, which we used in previous studies to 
exclude S-phase cells from the analysis (Löbrich et al., 2010). 
To study the impact of CtIP on DSB repair in G1, we depleted 
CtIP by siRNA, which reduces Rad51 foci formation and phos-
phorylation of the RPA2 (replication protein A subunit 2) after 
IR in G2, demonstrating the efficiency of the knockdown ap-
proach (Fig. S1 a). At all time points analyzed, we observed the 
same level of -H2AX foci in CtIP-depleted, G1-phase HeLa 
cells as in control cells, suggesting that CtIP is not required for 
DSB repair in G1 (Fig. 1 b). The same result was obtained using 
G1-phase 82-6 fibroblasts depleted for CtIP (Fig. S1 b).
We consolidated this finding by investigating chromo-
some breaks in G1-phase cells by using premature chromo-
some condensation (PCC), which involves fusing irradiated 
fibroblasts with mitotic HeLa cells. Condensed fibroblast 
chromosomes in G1 could be distinguished from condensed 
fibroblast chromosomes in G2 and from mitotic HeLa chro-
mosomes by their one-chromatid morphology (Gotoh and 
Durante, 2006). FISH was used to visualize chromosomes 1, 
2, and 4 in the condensed G1-phase fibroblast chromosomes 
(Fig. 1 c). Cell fusion was performed at varying times after IR 
to monitor the kinetics of repair. At all time points analyzed, 
CtIP-depleted cells showed similar levels of chromosome 
breaks as wt cells (Fig. 1 d).
Because CtIP depletion has been reported to reduce 
translocation and excision frequencies in reporter systems 
(Rass et al., 2009; Zhang and Jasin, 2011), we speculated 
that it might also reduce translocation levels after IR and 
investigated the formation of chromosome translocations in 
G1 cells by PCC/FISH analysis as described in the previous 
paragraph. To enhance sensitivity, we used a higher radia-
tion dose (7 Gy); at this dose, break repair kinetics were still 
unaffected by CtIP depletion (Fig. S1 c). Some transloca-
tions in wt cells formed with fast kinetics being detectable 
within 2 h after IR (the earliest time point that could be in-
vestigated as a result of the time needed for the PCC pro-
tocol). Between 2 and 6 h after IR, only a few additional 
translocations arose before a second component of transloca-
tion formation occurred at times >6 h after IR (Fig. 1 e). Of 
note, CtIP depletion strongly diminished translocation levels 
at later (>6 h) but not at earlier times (Fig. 1 e). We analyzed 
G2-irradiated cells with a two-chromatid morphology as a 
control and observed translocation levels substantially lower 
than in G1-irradiated cells. Moreover, CtIP depletion did not 
affect translocation formation in G2-irradiated cells (Fig. S1 d). 
translocations from restriction enzyme-induced DSBs (Zhang 
and Jasin, 2011). CtIP also has end-processing functions in G1, 
which are important to remove topoisomerase II from the DSB 
site before NHEJ can ensue (Nakamura et al., 2010; Quennet 
et al., 2011). Finally, CtIP can promote hairpin opening and re-
section during variable (diversity) joining recombination in 
G1-phase lymphocytes devoid of H2AX (Helmink et al., 2011).
CtIP is regulated during the cell cycle by Cdks and is a 
substrate of DNA damage-induced phosphorylation by ATM 
and ATR (Yu and Chen, 2004; Huertas et al., 2008; Peterson 
et al., 2013). Two Cdk sites, S327 and T847, regulate resec-
tion in S and G2 (Yu et al., 2006; Huertas and Jackson, 2009; 
Yun and Hiom, 2009), although the role of the S327 modifica-
tion during HR has been questioned (Nakamura et al., 2010; 
Reczek et al., 2013). Five additional Cdk sites in the central 
domain of CtIP have been identified and found to interact with 
NBS1, promoting ATM-dependent CtIP phosphorylation to 
activate resection and HR (Wang et al., 2013). However, in con-
trast to CtIP’s role in HR in G2, the mechanism regulating CtIP 
in G1 is unknown.
Polo-like kinases (Plks) are serine/threonine kinases. Sim-
ilar to Cdks, they phosphorylate substrates containing an [S/T]-P 
motif (Elia et al., 2003), whereas ATM and ATR phosphorylate 
[S/T]-Q sites (Kim et al., 1999). Plks contain a highly conserved 
N-terminal kinase domain and a C-terminal substrate-binding 
domain, termed the Polo box domain (PBD). Of the five Plks 
identified in mammalian cells, Plk1 is the best studied and regu-
lates mitosis and cytokinesis (Golsteyn et al., 1995; de Cárcer et al., 
2011). Plk3 is required for S-phase entry, and protein as well as 
mRNA levels are highest in G1 (Anger et al., 2003; Zimmerman 
and Erikson, 2007). Plk3 has been previously implicated in var-
ious stress responses (Bahassi et al., 2002), but a role in DSB 
repair was hitherto unknown.
Here, we show that Plk3 phosphorylates CtIP in G1-phase 
cells at T847 and S327 in a damage-inducible manner. We show 
that Plk3 and CtIP significantly contribute to the formation of 
translocations and other genomic rearrangements. Although Plk3 
and CtIP are not essential for DSB repair in G1 wt cells, they are 
required for alt-NHEJ processes that operate in G1 Ku/ mu-
tants. We show that complex DSBs undergo resection and repair 
in G1 via a process requiring Plk3 and its target sites on CtIP. 
Thus, we identify Plk3 as a novel regulator of an error-prone 
end-joining process in G1.
Results
CtIP enhances translocation formation  
in G1
Repair of IR-induced DSBs in G2 involves CtIP-dependent re-
section and HR, but it is unclear whether and how CtIP impacts 
on repair in G1. In one approach, we analyzed DSB repair 
kinetics in G1 cells by measuring -H2AX foci after IR using 
a semiautomated microscopic approach. We incubated the cells 
with nocodazole (a spindle inhibitor) and 5-ethynyl-2-deoxy-
uridine (EdU; a thymidine analogue) 30 min before IR and 
during the entire repair period and scanned them, after immuno-
fluorescence labeling, under the microscope. The EdU signal 
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Figure 1. CtIP enhances translocation formation in G1. (a) Identification of cell cycle phases (see first paragraph of the Results for description). arb. units, 
arbitrary units. (b) -H2AX foci in G1-phase HeLa cells after CtIP siRNA. (c) PCC spread from G1-phase 82-6 fibroblasts fused with mitotic HeLa cells. FISH 
staining was performed with chromosome probes 1, 2, and 4. The one-chromatid G1 PCC spread is encircled with a dashed line; the two-chromatid mitotic 
HeLa cell is outside this area. (d) Chromosome breaks in G1-phase 82-6 fibroblasts after CtIP siRNA. The image shows a chromosome break indicated by 
the presence of an additional fragment of the stained chromosome. (e) Translocations in G1-phase 82-6 fibroblasts after CtIP siRNA. The image shows a 
translocation indicated by the color junction (±SEM from at least three experiments). siCtrl, control siRNA; siCtIP, CtIP siRNA. *, P < 0.05.
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and below, only very faint pRPA2 signals could be detected 
(Fig. S1 e). We also wished to assess pRPA2 levels in G1 in-
stead of G0 cells and, therefore, trypsinized and reseeded G0 
cells before IR. Previous experiments had shown that G0 cells 
enter G1 and then progress into S phase at 12–16 h after 
trypsinization (Deckbar et al., 2010). At 4 h after trypsiniza-
tion, cells were still in G1 as demonstrated by the lack of any 
pRPA2 signal after treatment with CPT. Such cells showed 
significantly higher pRPA2 levels than G0 cells but still lower 
levels compared with proliferating cells (Fig. S1, f and g). We 
conclude from this biochemical analysis that resection does 
occur in G0/1 but is much more limited than in G2.
We next established detection of RPA phosphorylation at 
DSBs in G1 cells by immunofluorescence analysis because this 
allowed us to use siRNA and complementation approaches, which 
were difficult to perform with confluent cell cultures. First, we 
used x-irradiation and failed to detect robust pRPA foci forma-
tion in G1 cells, consistent with literature data. We then applied 
-particle irradiation, which induces DSBs that are more complex 
than x ray–induced DSBs and have a higher propensity to un-
dergo resection in G2 (Shibata et al., 2011). Distinct pRPA foci, 
which colocalize with -H2AX foci, could readily be detected in 
G1 and G2 cells, although the signal intensity was significantly 
lower in G1 (Fig. 2 c, left). pRPA foci formation was maximal be-
tween 2 and 6 h after IR and then decreased as a result of slow DSB 
repair (Fig. S1 h). Of note, robust foci formation was observed in 
nearly all G1 cells identified by the approach described in Fig. 1 a 
(Fig. 2 c). Most importantly, pRPA foci levels were strongly 
reduced after CtIP siRNA, confirming that they represent DSBs 
that were resected in a manner dependent on CtIP (Fig. 2 c). We 
also directly analyzed the presence of single-stranded DNA by 
the formation of BrdU foci (Beucher et al., 2009) and observed 
BrdU foci after -particle irradiation in a manner dependent on 
CtIP (Fig. 2 d). We conclude that CtIP impacts on DSB resection 
in G1, although robust evidence for resection is only observed 
after high radiation doses or the induction of complex DSBs, 
both of which enhances the level of resection that otherwise might 
escape detection by pRPA analysis.
CtIP function in G1 requires T847 and 
S327 phosphorylation
CtIP’s function during HR in G2 requires phosphorylation at 
the Cdk sites T847 and S327 (Yu et al., 2006; Huertas and Jack-
son, 2009; Yun and Hiom, 2009), although the role of the S327 
modification during HR has been questioned (Nakamura et al., 
2010; Reczek et al., 2013). To investigate whether these sites 
are required for CtIP’s resection function in G1, we transfected 
HeLa cells with wt or mutated GFP-CtIP plasmids (Fig. 3 a). 
 For this and all other transfection experiments, we used siRNA-
resistant plasmids and depleted the endogenous protein by siRNA. 
We investigated pRPA foci induced by  particles and observed 
robust foci levels in cells transfected with CtIP-wt. In contrast, cells 
transfected with CtIP-S327A or CtIP-T847A showed strongly 
diminished foci levels (Figs. 3 a and S2 a). These findings 
demonstrate that phosphorylations at the two Cdk sites T847 
and S327 are necessary for CtIP’s resection function in human 
G1 cells.
We conclude that CtIP functions in G1 and enhances translocation 
levels after IR, although the absence of CtIP does not alter 
DSB and chromosome break repair kinetics.
RPA loading and phosphorylation occurs in 
G1 at complex DSBs
After having shown that CtIP impacts on translocation forma-
tion in G1, we investigated whether the function of CtIP in G1 
involves resection. For this, we first examined RPA2 binding 
in 82-6 wt fibroblasts by Western blotting. To exclude any 
contribution from S or G2 cells, we used cell populations that 
were maintained in confluency for >4 wk, which resulted in 
>99.9% G0 cells (assessed by BrdU incorporation using FACS 
and immunofluorescence). We analyzed cytosolic and chro-
matin-bound protein levels and used proliferating 82-6 cell 
cultures as a control (Fig. 2 a). CtIP was present in the chro-
matin-bound fraction of confluent G0 cells, although at lower 
levels compared with proliferating cells (Fig. 2 a). The cyto-
solic Rad51 was strong in proliferating cells but weak in con-
fluent G0 cells, consistent with a previous study (Chen et al., 
1997). Chromatin-bound Rad51 was detectable in proliferat-
ing cells and increased after IR as described previously (Mladenov 
et al., 2006), but it was undetectable in confluent G0 cells. In 
contrast, cytosolic RPA2 was similarly present in proliferat-
ing and confluent cells. After IR, RPA2 levels strongly in-
creased in the chromatin-bound fraction of proliferating cells. 
Significantly, RPA2 was also detectable and increased after 
IR in the chromatin-bound fraction of confluent cells (Fig. 2 a). 
The absence of chromatin-bound Rad51 in confluent cells 
confirmed the absence of contaminating S/G2-phase cells 
(Fig. 2 a). However, the RPA2 signal was much weaker in 
confluent compared with proliferating cells.
We next wished to investigate RPA phosphorylation in 
G0, which is known to occur in G2 at chromatin-bound RPA2 
after damage induction (Anantha et al., 2007; Stephan et al., 
2009) in a manner dependent on CtIP (Fig. S1 a). We observed 
a weak but significant IR-induced pRPA2 signal in whole cell 
extracts from confluent 82-6 wt fibroblasts (Fig. 2 b). Treat-
ment with the S-phase damaging agent camptothecin (CPT) 
produced no detectable signal, confirming that the IR-induced 
pRPA2 signal is specific for G0 cells and cannot be attributed 
to contaminating S/G2-phase cells. Moreover, the confluent 
cell cultures were devoid of any CyclinA signal, a marker for 
S/G2 phase (Fig. 2 b). We also investigated the kinetics for the 
formation and disappearance of the pRPA2 signal. pRPA2 in-
creased in the first hours after IR, consistent with the time 
needed for resection (Fig. 2 b). At later times, pRPA2 de-
creased in parallel to the -H2AX signal, demonstrating that it 
represents repair occurring with slow kinetics instead of cell 
degeneration arising as a result of IR (Fig. 2 b). The latter no-
tion was further supported by the lack of any apoptotic signal, 
consistent with a previous study showing that human fibro-
blasts remain metabolically active even if irradiated with a 
dose of 80 Gy (Rief and Löbrich, 2002). Of note, this bio-
chemical analysis provides evidence for DSB resection in G0, 
although robust detection of RPA2 binding and phosphoryla-
tion requires a high radiation dose of 30 Gy. At doses of 15 Gy 
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CtIP-wt but not CtIP-S327A proteins showed a strong signal with 
the pS327 antibody, and CtIP-wt but not CtIP-T847A proteins 
showed a strong signal with the pT847 antibody (Fig. 3 b). Using 
these antibodies, we investigated the in vivo phosphorylation 
We then generated phosphospecific antibodies for de-
tecting CtIP-S327 and CtIP-T847 phosphorylations (CtIP-
pS327 and CtIP-pT847). CtIP proteins were expressed in 
insect cells, purified, and phosphorylated using Cdk2/CyclinA. 
Figure 2. RPA loading and phosphorylation occurs in G1 at complex DSBs. (a) Detection of cytosolic and chromatin-bound CtIP, RPA2, and Rad51 in 
proliferating (prol.) and confluency-arrested (G0) 82-6 fibroblasts 4 h after IR. The Rad51 signals are shown in two intensity settings (Rad51*, stronger 
intensity setting). GAPDH and H3 were used as markers for the cytosolic and chromatin-bound fraction, respectively. (b) Time course for the formation and 
disappearance of pRPA2 in whole cell extracts from confluency-arrested 82-6 fibroblasts. Caspase7, which provides a pronounced signal in cells treated 
with the apoptosis induction factor TNF and cycloheximide, was used to control for apoptosis. 1 µM camptothecin (CPT) treatment (for 1 h) was used to 
control for the presence of S-phase cells. (c and d) Detection of pRPA (c) and BrdU (d) foci in G1-phase HeLa cells treated with CtIP siRNA and irradiated 
with 2 Gy  particles. The mean number of foci per G1 cell (middle) and the fraction of G1 cells with more than five foci (right) are shown (±SEM from at 
least three experiments). siCtrl, control siRNA; siCtIP, CtIP siRNA. ***, P < 0.001.
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Figure 3. CtIP function in G1 requires S327 and T847 phosphorylation. (a) pRPA foci in GFP-positive (GFP+), G1-phase HeLa cells irradiated with 2 Gy 
 particles. Endogenous CtIP was depleted by siRNA, and cells were transfected with various GFP-CtIP plasmids. Knockdown efficiency for CtIP and trans-
fection efficiencies for GFP-CtIP were confirmed by Western blotting. endog., endogenous. (b) Insect cell–purified CtIP-wt, CtIP-S327A, and CtIP-T847A 
proteins were incubated with recombinant Cdk2/CyclinA and analyzed with phosphospecific antibodies for CtIP-pS327 or CtIP-pT847. (c) Phosphorylation 
of CtIP in vivo. HEK293T cells were treated with CtIP siRNA, transfected with GFP-CtIP-wt, GFP-CtIP-S327A, or GFP-CtIP-T847A plasmids, enriched in G1 
(≥90%), and irradiated with 5 Gy. GFP-CtIP was obtained by IP and analyzed for pS327 or pT847 by immunoblotting. (d) Analysis of excision events in 
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Plk3 is required for resection in G1 and 
phosphorylates CtIP in vitro
The Cdk1/2 inhibitor, roscovitine, diminished pRPA foci for-
mation in G2 cells but did not affect pRPA foci levels in G1 
cells (Fig. S3 a), suggesting that T847 and S327 phosphoryla-
tion in G1 is not mediated by Cdk1/2. Overexpression of the 
budding yeast homologue of the Plk family, Cdc5, leads to 
hyperphosphorylation of Sae2 (Donnianni et al., 2010), which 
is the homologue of CtIP (Sartori et al., 2007). In human cells, 
several Plk family members exist, of which Plk3 is required 
for S-phase entry (Anger et al., 2003; Zimmerman and Erikson, 
2007). Of note, Plk3 is phosphorylated and activated after IR 
in a manner dependent on ATM (Bahassi et al., 2002). We, 
therefore, investigated whether Plk3 is involved in CtIP phos-
phorylation in G1. We observed that pRPA and BrdU foci 
after -particle irradiation and the x ray–induced pRPA2 
signal on a Western blot were reduced after treatment with 
Plk3 siRNA or a Plk1/3 small molecule inhibitor (Plk inhibi-
tor [Plki]; Figs. 4 a and S3, a and b; Lansing et al., 2007), 
demonstrating that Plk activity is required for efficient resec-
tion in G1. As a control, we measured pRPA foci formation in 
G2 cells and observed the same foci level with and without 
Plk3 siRNA (Fig. S3 a). Additionally, Plk1 siRNA did not af-
fect pRPA foci formation in G1 or G2 (Fig. S3 a). This sug-
gests that the kinase requirement for resection is distinct in 
G1 (Plk3 dependent) versus G2 (Cdk1/2 dependent).
To provide evidence that Plk3 phosphorylates CtIP, 
we first performed in vitro kinase assays. We used HeLa 
cells either with or without GFP-CtIP expression, immuno-
precipitated either endogenous CtIP or GFP-CtIP, and added 
recombinant, constitutively active Plk3 protein. Phosphoryla-
tion was measured by 32P incorporation, and phosphorylation 
signals were obtained at molecular weights corresponding to 
those of CtIP or GFP-CtIP, demonstrating phosphorylation of 
CtIP and not of a CtIP-binding partner (Fig. 4 b). Moreover, 
the CtIP phosphorylation signal was diminished for CtIP 
mutated at the Cdk sites S327 and T847 but not for CtIP mu-
tated at the ATM-dependent phosphorylation sites S664 and 
S745 (Li et al., 2000), consistent with the notion that Plk3 
phosphorylates [S/T]-P but not [S/T]-Q sites (Fig. S3 c). We 
also used the phosphospecific antibodies to investigate CtIP 
phosphorylation by Plk3 in vitro. For this, we used insect cell 
purified CtIP, incubated it with recombinant Plk3 protein, and 
obtained robust phosphorylation signals at CtIP-S327 and 
CtIP-T847 (Fig. 4 c). Next, we studied CtIP phosphorylation 
in a gel shift experiment. Insect cell purified CtIP-wt protein 
incubated with recombinant Plk3 showed a substantial level of 
phosphorylation, which was diminished but not absent in the 
CtIP protein mutated at S327 and T847 to unphosphorylatable 
alanine (Fig. 4 d). This shows that Plk3 phosphorylates CtIP 
in vitro at S327, T847, and likely also at other sites. Finally, 
of CtIP in G1-enriched HEK293T cell populations. For this, 
we transfected the cells with GFP-CtIP using magnet-assisted 
transfection (MATra), which provided in this and all sub-
sequent experiments ≥90% transfected G1 cells (Fig. S2 b). We 
immunoprecipitated GFP-CtIP and observed for both anti-
bodies weak CtIP phosphorylation signals, which strongly in-
creased after irradiation. Of note, S327 phosphorylation 
increased strongly at 30 min after IR and then decreased to 
background values at 2 h after irradiation. T847 phosphoryla-
tion, in contrast, was very weak at earlier times and sharply 
peaked at 2 h after IR (Fig. 3 c). To exclude the possibilities 
that the observed phosphorylation pattern is a peculiarity of 
transformed cells and that S or G2 cells contribute to the sig-
nal, we investigated nontransformed confluent 82-6 fibro-
blasts. We observed IR-induced CtIP phosphorylation of S327 
at 30 min and of T847 at 2 h after IR (Fig. S2 c). Thus, CtIP 
phosphorylation occurs at both sites in vivo with a defined 
time course upon damage induction.
Finally, we wished to examine whether phosphorylation 
of the two phosphorylation sites T847 and S327 is important for 
the generation of genomic rearrangements. However, because of 
the limited transfection efficiency of CtIP plasmids, it was dif-
ficult to measure chromosomal translocations in CtIP comple-
mented cells by the PCC/FISH approach described in Fig. 1 e. 
We, therefore, used a reporter system, which detects the for-
mation of excisions (deletions) from the misrejoining of two 
I-SceI–induced DSBs (Fig. S2 d; Rass et al., 2009). Using this 
approach, we were able to measure excisions in cells treated 
with CtIP siRNA and efficiently complemented with various 
RFP-CtIP plasmids (Fig. 3 d). Of note, CtIP depletion lead to a 
reduction in excisions by 50%, demonstrating that a signifi-
cant proportion of such erroneous end-joining events arise from 
CtIP function. Cells transfected with CtIP-wt showed highly 
elevated excision levels, likely caused by CtIP overexpression 
(Fig. 3 d). But most importantly, cells expressing CtIP-S327A 
or CtIP-T847A showed the same low level of excisions as CtIP-
depleted cells without complementation (Fig. 3 d). The limita-
tion of this and other reporter systems is that cells cannot be 
maintained with sufficient accuracy in G1 for the entire time 
period necessary for I-SceI expression and excision formation 
(72 h). To investigate in which cell cycle phase such excisions 
are formed, we treated the cells with roscovitine, an inhibitor of 
Cdk1/2 that is required for CtIP-dependent resection in S/G2. 
Of note, roscovitine did not affect the excision levels but did 
diminish gene conversion frequencies in a classical HR reporter 
assay (Fig. S2 e). The same result was obtained after depletion 
of Cdk2 (Fig. S2 e). Therefore, the observed events likely re-
flect CtIP function during NHEJ in G1. In summary, the CtIP 
sites S327 and T847 are required for resection in G1, are phos-
phorylated in G1 in a damage-inducible manner, and mediate 
the formation of genomic rearrangements.
GC92 cells containing an NHEJ reporter substrate. Excision formation from the repair of two I-SceI–induced DSBs results in a CD4-positive signal. Cells 
were treated with CtIP siRNA and transfected with various RFP-CtIP plasmids. Excisions were measured by the fraction of RFP-positive cells that exhibited a 
CD4-positive signal relative to all RFP-positive cells. Results were normalized to control siRNA-treated cells that were transfected with an RFP empty vector. 
Knockdown efficiencies for CtIP and transfection efficiencies for RFP-CtIP plasmids were confirmed by Western blotting (±SEM from at least three experi-
ments). siCtrl, control siRNA; siCtIP, CtIP siRNA. ***, P < 0.001.
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manner dependent on ATM (Fig. S4 c; Bahassi et al., 2002), 
we investigated whether CtIP phosphorylation by Plk3 de-
pends on ATM activity. Of note, confluent 82-6 fibroblasts 
treated with an ATM inhibitor (ATMi) did not show the IR-
induced increase in CtIP phosphorylation (Fig. 5 b). The same 
was observed with G1-enriched HEK293T cells transfected 
with GFP-CtIP and treated with ATM siRNA (Fig. S4 d). 
Based on this observation, we predicted that ATM is needed 
for efficient resection and investigated BrdU foci formation 
after -particle irradiation (because ATM is involved in RPA 
phosphorylation, the pRPA foci assay could not be applied 
to investigate the requirement of ATM for resection). No-
tably, cells treated with ATMi showed strongly diminished 
levels of BrdU foci compared with control cells (Fig. 5 c). 
Collectively, these data establish that CtIP phosphorylation 
at S327 and T847 represents a damage-inducible process 
dependent on Plk3.
we immunoprecipitated GFP-CtIP or S protein–CtIP from 
HEK293T cells and incubated it in vitro with Plk3. We ob-
served CtIP-S327 and CtIP-T847 phosphorylation in the ab-
sence of Plk3, which increased after Plk3 incubation (Fig. S3 d). 
Analysis of these samples by mass spectrometry confirmed 
the presence of multiple phosphorylations in CtIP from un-
damaged cells and revealed additional Plk3 phosphorylation 
sites (Table 1).
Plk3 phosphorylates CtIP in vivo
We then investigated CtIP phosphorylation in vivo using the 
phosphospecific antibodies and G1-enriched HEK293T popu-
lations. For both antibodies, we observed a strong IR-induced 
increase in the pCtIP level, which was abolished in cells 
treated with Plk3 siRNA (Figs. 5 a and S4 a). These results 
were confirmed with confluent 82-6 fibroblasts (Fig. S4 b). 
Because Plk3 is phosphorylated and activated after IR in a 
Figure 4. Plk3 is required for resection in G1 and phosphorylates CtIP in vitro. (a) pRPA (left) and BrdU (middle) foci in G1-phase HeLa cells treated with 
Plk3 siRNA or Plki and irradiated with 2 Gy  particles. Knockdown efficiency for Plk3 was confirmed by Western blotting. Detection of pRPA2 at 4 h after 
IR or CPT (1 µM for 1 h) in whole cell extracts from confluency-arrested 82-6 fibroblasts with and without Plki (right). GAPDH was used as a loading control, 
and CyclinA was used as a marker for S/G2 cells. (b) Endogenous CtIP obtained by IP of CtIP from untransfected HeLa cells or GFP-CtIP obtained by IP of 
GFP from transfected HeLa cells was incubated in vitro with recombinant, constitutively active Plk3. Phosphorylation was measured by 32P incorporation. 
The bands representing pCtIP or GFP-pCtIP are indicated. (c) Insect cell purified CtIP-wt protein was incubated in vitro with Plk3 or Cdk2/CyclinA and ana-
lyzed with phosphospecific antibodies for CtIP-pT847 or CtIP-pS327. (d) Insect cell purified CtIP-wt and CtIP-S327A/T847A proteins were incubated in vitro 
with Plk3 and analyzed with an antibody against CtIP (±SEM from at least three experiments). siCtrl, control siRNA; siPlk3, Plk3 siRNA. ***, P < 0.001.
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Finally, we asked whether CtIP with phosphomimic sub-
stitutions at T847 and S327 can overcome the requirement for 
Plk3. We enumerated pRPA foci in G1-phase HeLa cells that 
were codepleted for Plk3 and CtIP and transfected with CtIP-wt 
or CtIP with phosphomimic substitutions at S327 and/or T847 
(S327E, T847E, or S327E/T847E). Cells transfected with CtIP-wt, 
with CtIP-S327E, or with CtIP-T847E but not cells transfected 
with CtIP-S327E/T847E showed diminished pRPA foci forma-
tion (Figs. 5 d and S4 e), demonstrating that only cells with 
phosphomimic substitutions at both CtIP sites can overcome the 
requirement for Plk3. Thus, this result provides strong evidence 
that Plk3 functions during CtIP-dependent resection in G1 by 
phosphorylating CtIP at S327 and T847.
Plk3 interacts with CtIP to promote 
resection in G1
Plks have been reported to bind to their targets in a phosphory-
lation-dependent manner using a C-terminal PBD. This prim-
ing event activates Plks, facilitating the phosphorylation of Plk 
targets at neighboring sites (Elia et al., 2003). We performed 
coimmunoprecipitation (IP; co-IP) experiments and observed 
interaction of endogenous Plk3 with GFP-CtIP in transfected 
HEK293T cells, which was increased after irradiation (Fig. 6 a). 
We then transfected HEK293T cells with Flag-tagged Plk3 and 
GFP-tagged CtIP plasmids and performed co-IP experiments 
30 min after IR. We detected robust interaction between Plk3 
and CtIP-wt and between Plk3 and CtIP-T847A mutants but not 
between Plk3 and CtIP-S327A mutants (Fig. 6 b). Moreover, 
Plk3 with deleted PBDs (Plk3-PBD) was unable to interact 
with any CtIP proteins (Fig. 6 b). The same result is obtained 
with Plk3 and CtIP precipitated from unirradiated cells (Fig. S5 a). 
These data demonstrate that Plk3 interacts via its PBDs with 
CtIP in a manner that is dependent on CtIP phosphorylation 
at S327. We then examined whether Plk3 binding to CtIP is 
required for CtIP phosphorylation at T847. First, we observed 
that cells with Plk3-PBD do not show the IR-induced increase 
in CtIP-S327 and -T847 phosphorylation (Fig. 6 c). Second, 
cells transfected with CtIP-T847A show phosphorylation at 
Table 1. Mass spectrometry reveals CtIP phosphorylation at S327 
and T847 after incubation with Plk3
Site CtIP CtIP + Plk3
S163 P P
S171 P P
T190 N U
S197 N P
S231 P P
S233 P P
T245 P N
S298 N U
T299 N U
T302 N P
S305 P P
S309 U U
S311 P P
T312 U U
S313 U N
T315 P P
T323 P P
S326 U P
S327 U P
T333 N P
T344 P P
S345 P P
S347 P P
S349 N P
T361 N P
T367 N U
S377 P U
S379 P U
S382 U P
T386 U U
S389 N P
S413 N P
S415 N P
S439 P P
T450 P N
S454 N U
T520 N P
T527 U U
S539 P P
T544 U P
S549 P U
S555 P P
S568 P P
S593 P P
T596 U P
S627 N P
S649 P U
T671 N P
S679 U N
T687 N P
T693 N P
S713 N P
S714 N P
S723 P P
T731 U N
S743 P N
S745 P N
Table 1. Mass spectrometry reveals CtIP phosphorylation at S327 
and T847 after incubation with Plk3 (Continued)
Site CtIP CtIP + Plk3
Y780 N P
T788 N U
S789 N U
T847 N P
T859 N U
Y867 N P
S889 P P
We analyzed CtIP immunoprecipitated and purified from stably transfected 
HEK293T cells with or without in vitro incubation with recombinant Plk3. All 
observed phosphorylation sites are shown. Statistical analysis (Ascore calcula-
tion) was performed at the Taplin Mass Spectrometry Facility (Harvard Medical 
School; Beausoleil et al., 2006). The sites were classified as P = phosphoryla-
tion (Ascore ≥ 19), U = unlikely phosphorylation (Ascore 0–18), and N = no 
phosphorylation. CtIP phosphorylation (Ascore ≥ 19) at S327 and T847 was 
detected with, but not without, Plk3 incubation. 17 additional CtIP sites were 
phosphorylated with Plk3 but not phosphorylated without Plk3 incubation. Note 
the high basal CtIP phosphorylation level without Plk3 incubation.
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Plk3 enhances the formation 
of translocations and genomic 
rearrangements in G1
Having established that CtIP’s function in G1 is regulated by 
Plk3, we sought to investigate the impact of Plk3 depletion on 
the formation of chromosome translocations. Addition of Plki 
as well as Plk3 siRNA did not affect the level of unrepaired 
DSBs or chromosome breaks (Fig. 7, a and b), consistent with 
the notion that CtIP is not required for break repair in G1. 
S327, but CtIP-S327A mutants fail to show phosphorylation 
at T847 (Fig. 6 d). Finally, we investigated whether Plk3-
PBD can efficiently promote resection and observed that 
Plk3-wt but not Plk3-PBD is able to restore pRPA foci lev-
els in Plk3 siRNA–treated cells (Fig. 6 e). Collectively, this 
shows that Plk3 binds via its PBDs to CtIP phosphorylated at 
S327, which primes further CtIP phosphorylation at S327 and 
is necessary for subsequent CtIP phosphorylation at T847 and 
efficient resection.
Figure 5. Plk3 phosphorylates CtIP in vivo. (a) HEK293T cells were treated with Plk3 and CtIP siRNAs, transfected with GFP-CtIP plasmids, enriched in G1 
(≥90%), and irradiated with 5 Gy. GFP-CtIP was obtained by IP and analyzed for pS327 at 30 min after IR or pT847 at 2 h after IR by immunoblotting. 
(b) Confluent 82-6 fibroblasts were treated with ATMi and irradiated with 5 Gy. Endogenous CtIP was obtained by IP and analyzed for pS327 at 30 min 
after IR or pT847 at 2 h after IR by immunoblotting. (c) BrdU foci in ATMi-treated, G1-phase HeLa cells irradiated with 2 Gy  particles. (d) pRPA foci in 
GFP-positive (GFP+), G1-phase HeLa cells after 2 Gy -particle irradiation. Cells were treated with CtIP and Plk3 siRNAs and transfected with GFP-CtIP 
plasmids. Knockdown efficiencies for CtIP and Plk3 as well as transfection efficiencies for GFP-CtIP were confirmed by Western blotting (±SEM from three 
experiments). endog., endogenous; siCtrl, control siRNA; siCtIP, CtIP siRNA; siPlk3, Plk3 siRNA. ***, P < 0.001.
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However, when we analyzed the formation of chromosome 
translocations after Plki and Plk3 siRNA by PCC/FISH analysis 
as in Fig. 1 d, we observed diminished translocation levels at 
Figure 6. Plk3 interacts with CtIP to promote resection in G1. (a) Interaction of GFP-CtIP and Plk3 after 5 Gy IR. HEK293T cells were treated with CtIP siRNA 
and transfected with a GFP-CtIP plasmid. GFP-CtIP or Plk3 were obtained by IP, and the precipitates were analyzed by immunoblotting. (b) Interaction of 
Plk3-PBD with CtIP-S327A and CtIP-T847A at 30 min after 5 Gy. HEK293T cells were treated with CtIP and Plk3 siRNAs and transfected with GFP-CtIP and 
SFB-Plk3 plasmids. Plk3 was obtained by IP, and the precipitates were analyzed by immunoblotting. (c) CtIP phosphorylation in a Plk3-PBD mutant in vivo. 
HEK293T cells were treated with CtIP and Plk3 siRNAs, transfected with GFP-CtIP and SFB-Plk3 plasmids, and irradiated with 5 Gy. GFP-CtIP was obtained by 
IP and analyzed for pS327 at 30 min after IR or pT847 at 2 h after IR by immunoblotting. (d) HEK293T cells were treated with CtIP siRNA, transfected with 
GFP-CtIP plasmids, and irradiated with 5 Gy. GFP-CtIP was obtained by IP and analyzed for pS327 or pT847 by immunoblotting. (e) pRPA foci in Flag-positive 
(Flag+), G1-phase HeLa cells after 2 Gy -particle irradiation. Cells were treated with Plk3 siRNA and transfected with SFB-Plk3 plasmids. Transfection efficien-
cies were confirmed by Western blotting (±SEM from three experiments). siCtrl, control siRNA; siPlk3, Plk3 siRNA. ***, P < 0.001.
late but not at early times (Fig. 7 c). As a control, we analyzed 
G2-irradiated cells and did not observe an impact of Plki or 
Plk3 siRNA on translocation formation (Fig. S5 b). This result 
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CtIP and enumerated -H2AX foci in G1 cells at various times 
after IR as described in Fig. 1 a. Of note, we observed similar ini-
tial foci levels but a substantial and epistatic repair defect after 
Plk3 and CtIP siRNA (Fig. 8 a). Thus, repair of complex DSBs 
with multiple lesions in close proximity requires Plk3/CtIP.
Another condition when DSBs cannot easily be repaired 
without resection occurs in c-NHEJ mutants, which repair DSBs by 
alt-NHEJ. To investigate whether this process requires Plk3/CtIP, 
we used Ku/ mouse embryonic fibroblasts (MEFs) and analyzed 
-H2AX foci in G1 cells that were identified as in Fig. 1 a. Con-
sistent with the described role of poly (ADP-ribose) polymerase 
(PARP) in alt-NHEJ (Wang et al., 2006), chemical inhibition of 
PARP increased the residual level of DSBs in Ku80/ MEFs but 
did not affect the repair capacity of wt MEFs (Fig. 8 b). To verify 
that PARP operates in alt-NHEJ, we codepleted Lig1 and 3, which 
are also implicated in alt-NHEJ (Wang et al., 2005). Dual deple-
tion of Lig1/3 increased residual DSB levels in Ku80/ MEFs 
similar to PARP inhibition but had no effect on wt cells (Fig. 8 b). 
PARP inhibition in Lig1/3-depleted cells conferred no greater 
is again in full agreement with the impact of CtIP siRNA on 
translocation formation. Finally, we analyzed the formation of 
excisions in Plk3-depleted cells using the reporter system de-
scribed in Fig. 3 d. We observed a reduction in excision events 
after Plk3 siRNA or Plki by 50% (Figs. 7 d and S5 c), similar 
to the reduction after CtIP siRNA. Dual depletion of Plk3 and 
CtIP had no further impact, confirming that both factors operate 
in the same error-prone repair pathway (Fig. 7 d). In contrast, 
Plki did not impact on gene conversion frequencies measured 
with an HR reporter assay, supporting the notion that Plk3 regu-
lation of CtIP is specific for G1 (Fig. S5 c).
Plk3 is required for the repair of complex 
DSBs and DSBs in G1-phase Ku/ MEFs
Although Plk3 and CtIP were not essential for the repair of 
x ray–induced DSBs in wt cells, we reasoned that they might be 
required under special conditions. Because resection in G1 could 
be readily detected at  particle–induced DSBs, we speculated 
that the repair of such complex breaks might require Plk3 and 
Figure 7. Plk3 enhances the formation of translocations and genomic rearrangements in G1. (a) -H2AX foci in G1-phase 82-6 fibroblasts treated with 
Plk3 siRNA or Plki. Plk3 knockdown efficiency was confirmed by Western blotting. (b) Chromosome breaks in G1-phase 82-6 fibroblasts treated with Plki. 
(c) Translocations in G1-phase 82-6 fibroblasts treated with Plk3 siRNA or Plki. (d) Analysis of excision events in GC92 cells. Cells were treated with CtIP 
and/or Plk3 siRNA, and excisions were measured by the fraction of cells that exhibited a CD4-positive signal relative to all cells. Results were normalized 
to control siRNA-treated cells. The knockdown efficiencies for CtIP and Plk3 were confirmed by Western blotting (±SEM from at least three experiments). 
siCtrl, control siRNA; siCtIP, CtIP siRNA; siPlk3, Plk3 siRNA. *, P < 0.05; ***, P < 0.001.
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Thus, these cell survival data fully recapitulate the DSB repair 
data in G1. We conclude that Plk3 and CtIP represent essential 
factors for the process of alt-NHEJ in G1.
Discussion
Mounting evidence suggests that CtIP is active in G1 and sup-
ports various important cellular processes. However, how CtIP 
is regulated during G1 phase is completely unknown. Here, we 
show that Plk3 phosphorylates CtIP in G1 in a damage-inducible 
manner to promote error-prone DSB repair. Hence, Plk3 repre-
sents a novel DSB response factor. We show that Plk3 impacts 
on various cellular processes. First, we show that Plk3 enhances 
impact, suggesting that PARP inhibition and Lig1/3 depletion 
impede the same alt-NHEJ pathway (Fig. 8 b). We then inhibited 
Plk3 and CtIP in Ku80/ MEFs and observed elevated unrepaired 
DSB levels similar to PARP inhibition. Inhibition of Plk3, CtIP, 
and PARP together did not further increase the residual DSB level, 
suggesting that Plk3 and CtIP function during PARP-dependent 
alt-NHEJ process (Fig. 8 c). As a control, we analyzed -H2AX 
foci in G2-irradiated Ku80/ MEFs and observed that CtIP 
siRNA but not Plki increased residual foci levels (Fig. S5 d). 
Finally, we investigated clonogenic cell survival in G1-irradi-
ated wt and Ku80/ MEFs. wt MEFs were not affected by Plki, 
but Ku mutants, which were already quite radiosensitive with-
out Plki, were even more radiosensitive after Plki (Fig. 8 d). 
Figure 8. Plk3 is required for the repair of complex DSBs and DSBs in G1-phase Ku/ MEFs. (a) -H2AX foci in G1-phase 82-6 fibroblasts treated with 
CtIP siRNA and/or Plki and irradiated with 2 Gy  particles. (b) -H2AX foci in G1-phase wt and Ku80/ MEFs treated with Lig1/3 siRNA and/or PARP 
inhibition (PARPi). Knockdown efficiencies were confirmed by Western blotting. (c) -H2AX foci in G1-phase wt and Ku80/ MEFs treated with CtIP siRNA 
and/or Plki and PARP inhibition. (d) Survival of G1-phase wt and Ku80/ MEFs after Plki. G1 cells were obtained by mitotic shake-off followed by 2-h 
incubation before IR (±SEM from at least three experiments; Jackman and O’Connor, 2001). siCtrl, control siRNA; siCtIP, CtIP siRNA; siLig1/3, Lig1/3 
siRNA. *, P < 0.05; ***, P < 0.001.
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activate this process, which might be regarded as the last resort 
to complete DSB repair before S-phase entry commences. This 
last resort, however, comes along with an increased likelihood 
for generating translocations. Of note, conceptually similar last 
resort mechanisms have been proposed for cells progressing 
though mitosis, where resolvases are activated late to process 
joint DNA molecules in mitosis (Lukas et al., 2011a; Naim 
et al., 2013; Ying et al., 2013).
CtIP function during G1 requires CtIP phosphorylation on 
T847 and S327, similar to CtIP’s function during HR in G2. 
Our analysis of the time course of CtIP phosphorylation has re-
vealed that S327 phosphorylation peaks sharply at 30 min and 
that T847 phosphorylation peaks sharply at 120 min after IR in 
G1. We demonstrate that both sites need to be phosphorylated 
for CtIP function in G1 and reveal the defined time course of 
events. In S/G2 phase, Cdks phosphorylate these sites, and it’s 
possible that the time course is different to that in G1 phase, 
which may reflect the distinct outcomes in terms of repair. In 
G2, HR requires avid resection; in G1, resection is more lim-
ited, and repair occurs by end-joining processes that require lit-
tle resection (Chapman et al., 2013; Di Virgilio et al., 2013; 
Escribano-Díaz et al., 2013; Feng et al., 2013; Zimmermann 
et al., 2013). Consistent with the more limited resection in G1, 
we failed to detect pRPA foci after x-irradiation. However, re-
section in G1 can be monitored after higher x-ray dose or by in-
ducing complex DSBs, which have a higher propensity to undergo 
resection than x ray–induced DSBs (Shibata et al., 2011).
We have studied the mechanism of CtIP phosphorylation 
by Plk3 and investigated the temporal interplay of CtIP phos-
phorylation at S327 and T847. Consistent with the literature 
(Bahassi et al., 2002), we observed that Plk3 is phosphorylated 
after IR in an ATM-dependent manner. Furthermore, Plk3 binds 
to CtIP phosphorylated at S327 via its PBD domains, which is 
necessary for robust CtIP phosphorylation at S327 and sub-
sequent CtIP phosphorylation at T847. The initial priming event 
(phosphorylation) before Plk3 binds at CtIP-pS327 via its PBD 
domains is either performed by Plk3 itself (a self-priming 
mechanism) or by a hitherto unknown kinase (a non–self-priming 
mechanism); both modes of action have been described for 
Plk1 and other factors regulating the cell cycle and damage re-
sponse (Reinhardt and Yaffe 2013; Lee et al., 2014). In the latter 
case, it is possible that Cdk4/6 mediates the initial CtIP phos-
phorylation in G1 to prime the Plk3 response. Although we 
favor the notion that the Plk3-mediated response is G1 specific, 
we cannot eliminate the possibility that it might be activated 
also in S/G2 and thus represents a more general stress-induced 
Plk3 response. Of note, the amplification process at CtIP-S327 
after Plk3 binding to CtIP-pS327 might involve the transphos-
phorylation of neighboring CtIP molecules by Plk3. Such a 
mechanism would provide a critical mass means for amplifica-
tion of CtIP phosphorylation at a DSB site (Fig. S5 e, model of 
CtIP phosphorylation by Plk3). Moreover, because a phospho-
mimic CtIP-S327E/T847E double mutant but not a CtIP-
T847E single mutant is able to rescue the resection defect of 
Plk3-deficient cells, CtIP-S327 phosphorylation not only serves 
to promote T847 phosphorylation but likely has another role in 
activating CtIP.
the formation of IR-induced translocations in G1-phase wt cells 
similar to CtIP; second, it promotes error-prone excision events 
from two restriction enzyme-induced DSBs in wt cells in a 
manner epistatic with CtIP; third, it is required for activating 
CtIP to support resection and repair of complex DSBs in G1; 
and finally, it is required for rejoining IR-induced DSBs in the 
absence of Ku by an alt-NHEJ process. In the following para-
graphs, we discuss the significance of the observation that Plk3 
mediates the activation of CtIP during these processes in a damage- 
induced manner.
Long-standing questions in cancer research concern the 
mechanisms underlying chromosome translocation formation 
(Nussenzweig and Nussenzweig, 2010). Translocations have 
been proposed to arise via NHEJ (Bunting and Nussenzweig, 
2013). However, c-NHEJ mutants show enhanced instead of 
reduced chromosomal translocations, suggesting that, in the ab-
sence of c-NHEJ factors, translocations are formed by alt-NHEJ 
processes (Weinstock et al., 2007; Boboila et al., 2010). A re-
cent study has provided evidence that a CtIP-dependent process 
exposes microhomologies and causes translocations from re-
striction enzyme-induced DSBs (Zhang and Jasin, 2011). Here, 
we have focused our analysis on G1-phase cells because most 
cells in a human body are in G0/G1 phase, and we have used 
x rays to induce DSBs because radiation exposure, even at low 
doses (e.g., after computer tomography scans), can cause cancer 
(Pearce et al., 2012). We show that a substantial fraction of 
IR-induced translocations in G1 arise from a Plk3- and CtIP-
dependent process. Moreover, also, genomic rearrangements 
arising from the misrejoining of two restriction enzyme–induced 
DSBs are promoted by Plk3 and CtIP. Thus, Plk3 represents 
a novel DSB response factor, which is involved in error-prone 
DSB repair processes underlying the formation of chromosome 
translocations and other genomic rearrangements.
Translocation formation ≤6 h after IR in G1 occurs in a 
manner independent of CtIP, with most translocations in this 
component arising during the first 2 h. This suggests that trans-
locations can form very quickly after damage induction, an ob-
servation consistent with previous findings (Darroudi et al., 
1998). However, we observed a second component of translo-
cation formation at >6 h, which is dependent on Plk3 and CtIP. 
The occurrence of Plk3/CtIP-dependent translocations with 
slow kinetics is consistent with the delayed phosphorylation 
and activation of CtIP. Conceptually, this delay provides a sen-
sible mechanism to initiate CtIP-dependent processing only if 
the cells fail to repair the DSBs by a CtIP-independent process. 
This is the case in Ku-deficient cells, in which repair ensues by 
alt-NHEJ, but also occurs in wt cells at complex DSBs. Thus, 
the model emerges that cells first try to repair DSBs without 
CtIP function and, only if this fails, activate CtIP by Plk3. We 
would like to point out in this context that we did not investigate 
the issue of pathway usage for DSBs that are resected in G1 wt 
cells by Plk3/CtIP. Although such breaks clearly undergo repair 
by alt-NHEJ in Ku-deficient cells, c-NHEJ as well as alt-NHEJ 
might be capable of repairing resected DSBs in wt cells. Be-
cause Plk3 is required for G1–S transition in unperturbed cells 
(Zimmerman and Erikson, 2007) and is itself activated by IR 
(Bahassi et al., 2002), this kinase seems to be perfectly suited to 
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(SI05056450), control (5-AATTCTCCGAACGTGTCACGT-3), mouse CtIP 
(5-AAACAGATACTTACAAATAAA-3), mouse Lig1 (5-CAGGAAAGTAT-
CCTGACATTA-3), and mouse Lig3 (5-GCACAAAGATTGTCTGCTA-3).
NHEJ and HR reporter assays
GC92 cells containing an NHEJ substrate (Rass et al., 2009) and HeLa 
pGC cells containing a HR substrate (Mansour et al., 2008) were fixed 
and stained 72 h after transfection with I-SceI. 15,000 cells per sample 
were analyzed with a microscope (Axiovert 200M; Carl Zeiss) and Metafer 
software (MetaSystems).
Irradiation and chemical treatment
If not mentioned otherwise, irradiation was performed with x rays at 90 kV 
and 19 mA. When stated, -particle irradiation was performed with a 
241Am source (Kühne et al., 2000). Chemical inhibitors were added 1 h 
before IR or 6 h after transfection with I-SceI and maintained during repair 
incubation. The ATMi Ku60019 (Tocris Bioscience), Cdk1/2 inhibitor 
roscovitine (Sigma-Aldrich), the Plki GW 843682X (half-maximal inhibi-
tory concentration values of 2.2 and 9.1 nM for Plk1 and Plk3, respec-
tively; Tocris Bioscience), and the PARP inhibitor PJ34 (EMD Millipore) were 
used at concentrations of 0.5, 25, 0.5, and 15 µM, respectively. Cells 
were treated with 1 µM CPT (Sigma-Aldrich) for 1 h.
Chromosomal analysis
For translocation and chromosome break analysis of G1 cells, exponen-
tially growing 82-6 fibroblasts were irradiated and treated with 100 ng/ml 
nocodazole to prevent G2-irradiated cells from progressing into G1 during 
repair incubation. At the end of repair incubation, cells were mixed at a 
ratio of 1:1 with mitotic HeLa cells (enriched by treatment with colcemid for 
20 h). After centrifugation, cell fusion was mediated by adding 0.25 ml 
polyethylene glycol 1500 (Roche) for 1 min to the cell pellet (Mosesso 
et al., 1999). For translocation measurements in G2-irradiated cells, expo-
nentially growing 82-6 fibroblasts were irradiated, incubated in the pres-
ence of EdU for 14 h, and harvested by adding 50 ng/ml calyculin A for 
30 min. Only EdU-negative G2 PCC spreads with two-chromatid morphol-
ogy were evaluated. G1 and G2 PCC spreads were prepared by hypo-
tonic treatment with 0.075 mM KCl and fixation using 3:1 methanol/acetic 
acid. FISH experiments using whole chromosome probes 1, 2, and 4 were 
performed following the manufacturer’s protocol (MetaSystems). Slides 
were processed using a microscope (Axioplan 2; Carl Zeiss), an EC Plan 
Neofluar (63×) with a numerical aperture of 1.25 (Carl Zeiss), and Metafer 
software. Translocations as well as chromosome breaks were scored in the 
stained chromosomes 1, 2, and 4. Color junctions between two stained 
chromosomes or between a stained and an unstained chromosome repre-
sent translocations. An additional fragment that is not connected to another 
stained or unstained chromosome is counted as a chromosome break. At 
least 200 PCC spreads were analyzed per data point.
Protein extracts, IP, and immunoblotting
For preparation of whole cell extracts, cells were resuspended in radio-
immunoprecipitation assay buffer containing 50 mM Tris/HCl, pH 8, 
150 mM NaCl, 0.5% natriumdesoxycholat, 1% Triton X-100, 0.1% SDS, 
freshly added protease inhibitor cocktail (1:25), and PhosSTOP (1:10) and 
sonicated three times for 1 min (Quennet et al., 2011). For chromatin frac-
tionation, cells were resuspended in Chelsky buffer (10 mM Tris/HCl, pH 
7.5, 10 mM NaCl, 3 mM MgCl2, and 30 mM sucrose) containing 0.5% 
NP-40 and centrifuged for 10 min at 400 g. The supernatant represented 
the cytosolic fraction. The pellet was washed once in Chelsky buffer con-
taining 0.5% NP-40 and twice in Chelsky buffer containing 10 mM CaCl2 
(10 min, 1500× g). Cell pellet was resuspended in 20 mM Tris/HCl, pH 
7.9, 100 mM KCl, 0.2 mM EDTA, and 20% glycerol containing protease 
inhibitor and incubated 10 min on ice. After centrifugation (10 min at 
1,500 g), chromatin fraction was lysed in radioimmunoprecipitation assay 
buffer. For IP, antibodies (2 µg) were linked to Dynabeads Protein G (In-
vitrogen), washed three times in 0.1% BSA/PBS, and then incubated with 
the cell extract at 4°C overnight. The membrane was blocked for 1 h in 
5% low fat milk or 5% BSA in TBS/0.1% Tween 20. Immunoblotting was 
performed in TBS/0.1% Tween 20/1% low fat milk or 5% BSA overnight 
at 4°C or for 2 h at room temperature followed by HRP-conjugated sec-
ondary antibody incubation in PBS/0.1% Tween 20/1% low fat milk or 
5% BSA for 1 h. Immunoblots were developed using ECL (Roche). Signal 
detection was performed with an image acquisition system (Chemi-Smart; 
Vilber Lourmat). For detection of pCtIP (T847 or S327), HEK293T cells 
transfected with GFP-CtIP plasmids were immunoprecipitated with mouse 
-GFP (Santa Cruz Biotechnology, Inc.). Primary antibodies were rabbit 
-ATM at 1:500 (Abcam), rabbit –cleaved Caspase7 at 1:1,000 (Cell 
Our finding that CtIP phosphorylation on S327 and T847 
promotes an error-prone DSB repair process in G1 might ex-
plain the observation that mice with unphosphorylatable CtIP-
S327A do not display elevated cancer rates (Reczek et al., 
2013), although it was previously shown that CtIP phosphory-
lation at this site is required for efficient HR (Yu et al., 2006; 
Yun and Hiom, 2009). Our finding that the kinase Plk3 regulates 
CtIP during this error-prone end-joining process in G1 might 
be clinically important because some tumors exhibit increased 
Plk3 levels (Weichert et al., 2004, 2005). Thus, Plk3 inhibition 
might have a beneficial effect during tumor treatment by lower-
ing the capacity of a tumor cell to develop genomic instabil-
ity. Moreover, Plk3 inhibition can sensitize tumors that rely on 
CtIP-dependent DSB repair in G1, such as tumors with defects 
in c-NHEJ factors.
Materials and methods
Cell lines and cell culture
Immortalized and transformed cell lines were 82-6 hTert (wt), HeLa, HeLa 
pGC, GC92, HEK293T, and wt and Ku80/ MEFs. HeLa, HeLa pGC, 
GC92, HEK293T, and MEFs were cultured in DMEM with 10% FCS and 
1% NEAA (plus 0.3 µg/ml puromycin for HeLa pGC or 2 mM l-glutamine 
for HEK293T cells), and 82-6 cells were cultured in MEM with 20% FCS 
and 1% NEAA. All cells were maintained at 37°C in a 5% CO2 incuba-
tor. HeLa pGC cells contained an HR substrate carrying an inactive GFP 
gene with an I-SceI recognition site and a truncated GFP gene that was 
positioned in the same orientation on the other side of a puromycin selec-
tion cassette (Mansour et al., 2008). The GC92 cell line was derived from 
SV40-transformed GM639 human fibroblasts and contained the NHEJ sub-
strate described in Fig. S2 d (Rass et al., 2009). Ku80/ MEFs (provided 
by G. Li, Memorial Sloan Kettering Cancer Center, New York, NY) were 
obtained from Ku80/ mice.
RNA interference and plasmid transfection
In all transfection experiments, the endogenous protein was depleted by 
siRNA, and siRNA-resistant plasmids were used. siRNA treatment of 
HeLa, 82-6, and MEFs was performed using HiPerFect Transfection Re-
agent (QIAGEN) following the manufacturer’s instructions. Experiments 
were performed 48 h after siRNA treatment. 8 h after incubation with 
siRNA, HeLa cells were transfected with various GFP-tagged siRNA-
resistant CtIP plasmids (Quennet et al., 2011). HeLa pGC and GC92 
cells were treated with siRNA using HiPerFect Transfection Reagent 
and, 48 h later, transfected with the pBL464-pCBASce plasmid (I-SceI en-
donuclease) using jetPEI transfection reagent (Polyplus Transfection), 
and again treated with siRNA after another 6 h. GC92 cells were addi-
tionally transfected 24 h after the first siRNA treatment with various RFP-
tagged siRNA-resistant CtIP plasmids using jetPEI transfection reagent. 
Transfection of HEK293T cells with various siRNA-resistant GFP-tagged 
CtIP plasmids and SFB-tagged Plk3 plasmids was performed using 
MATra (IBA) following the manufacturer’s instruction. This transfection 
protocol provided >90% G1 cells (Fig. S2 b). Human full-length Plk3 
and a Plk3 deletion mutant (Plk3-PBD; aa 1–480) were transferred 
into an N-terminal triple epitope tag destination vector (SFB [S protein 
tag, Flag epitope tag, and streptavidin-binding peptide tag]) using 
Gateway LR Clonase Enzyme mix kit (Life Technologies) following the 
manufacturer’s instruction. The siRNA-resistant CtIP plasmids were ob-
tained by subcloning the human CtIP cDNA into a pEGFP-C1 or ptagRFP-
C1 vector (Takara Bio Inc.) and changing three nucleotides in the 
CtIP_2 siRNA targeting region (C133T, A135G, and A138G). The 
plasmids expressing the phosphorylation mutants were generated by 
site-directed mutagenesis.
siRNA
siRNA sequences used were human ATM (5-CACCGTTTTGTTAGTTTATTA-3), 
human Cdk2 (SI02654631), human CtIP_1 (5-TCCACAACATAATCC-
TAATAA-3; used for chromosomal experiments), human CtIP_2 (5-AAGCTA-
AAACAGGAACGAATC-3; used for all other experiments), human Plk1_2 
(SI00071624), human Plk1_6 (SI02223837), human Plk3 (5-CTGCAT-
CAAGCAGGTTCACTA-3), human Plk3_1 (SI00059388), human Plk3_11 
 o
n
 January 18, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published September 29, 2014
JCB • VOLUME 206 • NUMBER 7 • 2014 892
the phosphorylated S327 or T847 in the human CtIP sequence. To remove 
the cross-reacting antibody from the affinity-purified pT847 rabbit poly-
clonal antibody solution, the anti-pT847 antibody was incubated with 
equal amounts of Flag-tagged CtIP (T847A) protein overnight at 4°C in the 
presence of anti-Flag magnetic beads. Magnetic beads were separated 
from the supernatant, which was diluted to 10× the initial volume, and 
glycerol concentration was adjusted to 30%. The resulting solution of puri-
fied antibody was stored at 20°C.
Plk3 in vitro kinase assays
HeLa cells were transiently transfected with pEGFP-C1 and pEGFP-CtIP con-
structs, and proteins were obtained by IP against GFP (mouse -GFP; Santa 
Cruz Biotechnology, Inc.). Endogenous CtIP was obtained by IP against 
CtIP (mouse -CtIP). 0.32 µg Plk3 (Life Technologies) was diluted in 20 µl 
kinase buffer (25 mM Tris, pH 7.5, 10 mM MgCl2, 0.5 mM EGTA, 0.5 mM 
Na3VO4, 2.5 mM DTT, 0.01% Triton X-100, and 200 µM ATP) and incu-
bated for 15 min at 30°C. The kinase buffer containing Plk3 was added to 
the immunoprecipitated CtIP, GFP, or GFP-CtIP. The 32P kinase assay was 
performed in the presence of 5 µCi [32P]ATP for 30 min at 30°C, and gels 
were analyzed by audiography after SDS-PAGE. The kinase assay using 
phosphospecific antibodies was performed in the presence of 400 µM ATP 
for 30 min at 30°C.
Cdk in vitro kinase assay
200 ng wt, S327A, or T847A recombinant CtIP protein was phosphory-
lated using Cdk2/CyclinA (P6025S; New England Biolabs, Inc.) in the 
presence of 1 mM ATP at 30°C for 1 h. Reactions were analyzed by SDS-
PAGE and by immunoblotting using 1 µg/ml anti-pT847 antibody.
Mass spectrometry
HEK293T cells stably expressing SFB-tagged CtIP were selected by cultur-
ing in medium with 2 µg/ml puromycin. For affinity purification, HEK293T 
cells were lysed in NETN buffer (100 mM NaCl, 20 mM Tris-Cl, pH 8.0, 
0.5 mM EDTA, and 0.5% [vol/vol] Nonidet P-40) with protease and phos-
phatase inhibitors. Lysates were incubated with S protein beads (EMD Mil-
lipore) for 2 h at 4°C. The beads were washed four times with NETN 
buffer, and the bound proteins were subjected to SDS-PAGE. Protein bands 
were excised and analyzed by mass spectrometry at the Taplin Mass Spec-
trometry Facility, Harvard Medical School (Beausoleil et al., 2006).
Colony formation assay
G1-phase MEFs were obtained by mitotic shake-off. For this, the cell culture 
flasks were softly knocked to collect mitotic cells, which were then reseeded 
in new dishes and irradiated after 2 h when they were in G1 (Jackman and 
O’Connor, 2001). 30 min before IR, cells were treated with Plki. 9 h after 
IR, the medium containing Plki was replaced by fresh medium without Plki. 
After 7 d, colonies were fixed and stained with 0.1% crystal violet in 25% 
ethanol. Colonies containing ≥30 cells were counted.
Statistical analysis
All data shown represent the mean value of at least three independent ex-
periments. Background foci (<0.5 per cell), chromosome breaks (<0.1 per 
cell), and translocations (<0.01 per cell) were subtracted. The error bars 
show the SEM between the experiments. P-values were obtained by t test 
and represent a comparison of all cells analyzed in the indicated cell popu-
lations (for all foci and chromosomal experiments) or a comparison of the 
data mean (for data obtained with the NHEJ and HR reporter assay, the 
colony formation assay, and the 32P in vitro phosphorylation assay).
Online supplemental material
Fig. S1 (for Figs. 1 and 2) demonstrates the efficiency of the CtIP knock-
down approach, shows that CtIP is not required for G1-phase DSB and 
chromosome break repair, and presents evidence for RPA phosphorylation 
in G0 and G1 cells using Western blotting and for pRPA foci formation in 
G1 cells using immunofluorescence analysis. Fig. S2 (for Fig. 3) shows that 
pRPA foci formation in G1 requires CtIP phosphorylation at S327 and 
T847, confirms that CtIP is phosphorylated in vivo at S327 and T847, and 
reveals that genomic rearrangements require CtIP but not Cdk2. Fig. S3 
(for Fig. 4) shows that Plk3 is required for resection in G1 but not in G2, 
whereas roscovitine treatment affects resection in G2 but not in G1 and 
confirms that Plk3 phosphorylates CtIP in vitro at S327 and T847. Fig. S4 
(for Fig. 5) shows that Plk3 phosphorylates CtIP at S327 and T847 in vivo, 
reveals that these phosphorylation events require ATM, and confirms that 
pRPA foci formation in G1 requires CtIP phosphorylation at S327 and 
T847 by Plk3. Fig. S5 (for Figs. 6, 7, and 8) confirms that Plk3 interacts with 
CtIP phosphorylated at S327 in a manner dependent on its PBD domains, 
Signaling Technology), mouse -Cdk2 at 1:1,000 (Santa Cruz Biotech-
nology, Inc.), mouse -CtIP at 1:1,000 (Santa Cruz Biotechnology, Inc.), 
rabbit -pCtIP (T847) at 1:200, rabbit -pCtIP (S327) at 1:1,000, rab-
bit -CyclinA at 1:1,000 (Santa Cruz Biotechnology, Inc.), mouse -Flag 
(OctA) at 1:1,000 (Santa Cruz Biotechnology, Inc.), rabbit -GAPDH at 
1:1,000 (Santa Cruz Biotechnology, Inc.), rabbit -GFP at 1:1,000 (Santa 
Cruz Biotechnology, Inc.), mouse –-H2AX at 1:1,000 (EMD Millipore), 
mouse -H3 at 1:2,000 (Abcam), rabbit -Plk3 at 1:1,000 (Santa Cruz 
Biotechnology, Inc.), rabbit -Rad51 at 1:2,000 (Abcam), mouse -RPA2 
at 1:1,000 (EMD Millipore), rabbit -pRPA2 (S4/8) at 1:10,000 (Bethyl 
Laboratories, Inc.), and mouse -tubulin at 1:2,000 (Santa Cruz Biotech-
nology, Inc.).
Immunofluorescence
Cells were grown on glass coverslips. 1 µM EdU was added before ir-
radiation to label S-phase cells, and 100 ng/µl nocodazole was added 
immediately after IR to prevent G2-phase cells progressing into G1 dur-
ing repair incubation (Löbrich et al., 2010). For -particle irradiation, cells 
were grown on Mylar foil. Cells were fixed 15 min in PBS/2.5% formal-
dehyde, permeabilized 10 min in PBS/1% FCS/0.5% Triton X-100, and 
blocked 30 min in PBS/1% FCS/5% BSA. Samples were incubated with 
primary antibodies overnight at 4°C, washed three times in PBS/1% FCS, 
and incubated for 1 h at room temperature with Alexa Fluor 488– or 
Alexa Fluor 594–conjugated secondary antibodies (1:1,000; Invitrogen). 
After three washes in PBS, cells were DAPI (Sigma-Aldrich) stained and 
mounted using Vectashield mounting medium (Vector Laboratories; Quennet 
et al., 2011). For BrdU foci analysis, cells were preextracted 10 min with 
PBS/0.5% Triton X-100, fixed 20 min in PBS/2.5% formaldehyde, per-
meabilized 20 min in PBS/1% FCS/0.5% Triton X-100, and blocked 
20 min in PBS/1% FCS/5% BSA. Antibodies were mouse -BrdU at 1:200 
(BD), mouse –-H2AX at 1:2,000, rabbit –-H2AX at 1:2,000 (Abcam), 
mouse -GFP at 1:200 (Roche), rabbit -tagRFP at 1:2,000 (Evrogen), 
rabbit -pRPA (pT21) at 1:15,000 (Abcam), and rat -mouse CD4-FITC at 
1:100 (BioLegend). To stain EdU, the EdU staining kit (Invitrogen) was used 
following the manufacturer’s instructions. Foci counting was performed on 
a microscope (Axio Imager.M1; Carl Zeiss), and imaging was performed 
on an inverted microscope (Axiovert 200M; Carl Zeiss). Objectives used 
were an EC Plan Neofluar (100×) with a numerical aperture of 1.3 or 
a Plan Apochromat (20×) with a numerical aperture of 0.8 (Carl Zeiss). 
Imaging was performed at room temperature using a camera (AxioCam 
MRm; Carl Zeiss) and AxioVision acquisition software (Carl Zeiss). Images 
were processed using ImageJ (National Institutes of Health). Samples were 
evaluated blindly.
Human CtIP expression
An expression construct for CtIP-wt was generated by PCR from a pBSK-
CtIP construct (gift from W.-H. Lee, University of California, Irvine School of 
Medicine, Irvine, CA) to generate an N-terminal, Flag-tagged wt allele in 
pFastBac1 (Invitrogen). S327A and T847A mutants were generated by 
mutagenesis (QuikChange; Agilent Technologies). Transfer vectors were 
converted into corresponding bacmids and were used to make the virus 
according to the manufacturer’s instructions for the baculovirus expression 
system (Bac-to-Bac; Invitrogen). The wt and mutant CtIP proteins were ex-
pressed in Sf21 insect cells.
CtIP protein purification
Cells were lysed in buffer A (20 mM Tris, pH 8.0, 100 mM NaCl, 10% 
glycerol, and 1 mM DTT) supplemented with 0.5% Triton X-100, 2.5 mM 
Na4P2O7, 1 mM glycerol--phosphate, and 5 mM PMSF. Lysate was soni-
cated on ice until homogenous, and insoluble material was removed by 
centrifugation (100,000 g) for 1 h at 4°C. Supernatant was bound to 2 ml 
anti-Flag M2 agarose resin slurry (Sigma-Aldrich) at 4°C for 1 h, and then, 
resin was washed with 20 ml buffer A followed by 10 ml of 0.5-M LiCl and 
20 ml buffer A. The protein was eluted with 10 ml buffer A containing Flag 
peptide (Sigma-Aldrich) at a concentration of 100 µg/ml. Eluted protein 
was loaded onto a 1 ml HiTrap SP column (GE Healthcare), washed with 
20 ml buffer A, and eluted with buffer A containing 0.6 M NaCl. The peak 
fractions were dialyzed twice against 300 ml of fresh buffer A for 1 h at 
4°C and flash frozen in liquid nitrogen. Protein concentration was deter-
mined by Coomassie staining of the proteins separated by SDS-PAGE and 
compared with known standards.
Anti-pS327 and anti-pT847 antibody preparation
Phosphospecific antibodies were produced in rabbits against CtIP-pS327 and 
CtIP-pT847 (custom antibody service from PhosphoSolutions). The antigens 
were synthetic phosphopeptides corresponding to amino acids surrounding 
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Figure S1.  Translocation formation and RPA phosphorylation occurs in G1. (a) Efficient knockdown of CtIP in HeLa cells was confirmed by diminished 
pRPA2 signal on a Western blot and by reduced Rad51 foci formation after IR. (b) -H2AX foci in G1-phase 82-6 fibroblasts after CtIP siRNA. Knockdown 
efficiency was confirmed by Western blotting. (c) Chromosome breaks in G1-phase 82-6 fibroblasts after CtIP siRNA and 7 Gy. (d) Translocations in G1- 
and G2-phase 82-6 fibroblasts after CtIP siRNA. The data for G1 were taken from Fig. 1 e. The image shows a G2-phase translocation (indicated by the 
color junction) involving a fusion of two chromatids from two different chromosomes. Such a chromatid-type exchange is indicative of G2-irradiated cells 
and represents a typical G2-phase translocation. (e) Dose dependency for the formation of pRPA2 in whole cell extracts from confluency-arrested 82-6 fi-
broblasts 4 h after IR. (f) Detection of pRPA2 and CtIP in whole cell extracts from confluency-arrested (G0) and G1-phase 82-6 fibroblasts 4 h after IR or 1 
µM camptothecin (CPT). To obtain G1 cells, G0 cells were reseeded in fresh medium for 4 or 12 h. (g) Detection of pRPA2 in whole cell extracts from prolif-
erating (prol.), confluency-arrested (G0), and G1-phase (4 h after reseeding) 82-6 fibroblasts 4 h after IR. (h) Time course for the formation and disappear-
ance of pRPA foci in G1-phase HeLa cells after 2 Gy -particle irradiation (±SEM form at least three experiments). siCtrl, control siRNA; siCtIP, CtIP siRNA. 
*, P < 0.05; ***, P < 0.001.
JCB S2 
Figure S2.  CtIP function in G1 requires S327 and T847 phosphorylation. (a) Fraction of GFP-positive (GFP+), G1-phase HeLa cells with more than five 
pRPA foci after 2 Gy -particle irradiation. Endogenous CtIP was depleted by siRNA, and cells were transfected with various GFP-CtIP plasmids. Trans-
fection efficiencies were confirmed by Western blotting and immunofluorescence. (b) Cell cycle distribution of HEK293T cells transfected with GFP-CtIP-
wt using MATra analyzed at 2 h after IR. To differentiate between G1- and early S-phase cells, we have labeled the cells with EdU and measured the 
DNA content (DAPI), the EdU, and the GFP signal. We observed that efficiently transfected GFP-positive cells showed a pronounced enrichment in G1, 
whereas cells of the same sample that were not transfected were not enriched in G1 (in all experiments, we observed that >90% of GFP-positive cells ar-
rested in G1, but only >30% of GFP-negative cells arrested in G1). We attribute this difference to the stress caused by the transfection procedure. The 
data shown are from a single representative out of three repeats (green circles, G1 phases; blue circles, S phases; red circles, G2 phases; numbers indi-
cate the percentages of cells in the respective cell cycle phases). For the experiment shown, n = 2,121 (whole cell population) and n = 178 (GFP-positive 
cell population). arb. unit, arbitrary unit. (c) Phosphorylation of CtIP in vivo. Endogenous CtIP was obtained by IP from confluent 82-6 fibroblasts and 
analyzed for CtIP-pS327 or CtIP-T847 by immunoblotting at various time points after IR. (d) Schematic diagram of the assay monitoring excision events 
in GC92 cells (according to Rass et al., 2009). Excision formation from the repair of two I-SceI–induced DSBs results in CD4-positive cells that are de-
tected under the microscope. CMV, cytomegalovirus. (e, left) Analysis of excision events in GC92 cells. Cells were treated with CtIP or Cdk2 siRNA or 
incubated with roscovitine, and excisions were measured by the fraction of cells that exhibited a CD4-positive signal relative to all cells. Efficient knock-
down of Cdk2 was confirmed by Western blotting. (right) Analysis of gene conversion events in HeLa pGC cells carrying an integrated GFP reporter 
system. Cells were treated with CtIP or Cdk2 siRNA or incubated with roscovitine, and gene conversions were measured by the fraction of cells that ex-
hibited a GFP-positive signal relative to all cells. Results were normalized to untreated cells (±SEM from at least three experiments). rel., relative; siCtrl, 
control siRNA; siCtIP, CtIP siRNA; siCDK2, CDK2 siRNA. ***, P < 0.001.
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Figure S3.  Plk3 is required for resection in G1 and phosphorylates CtIP in vitro. (a) pRPA foci in G1- and G2-phase HeLa cells treated with Plk1 or Plk3 
siRNA or incubated with roscovitine and irradiated with 2 Gy  particles. Efficient knockdown was confirmed by Western blotting. (b) Fraction of G1-phase 
HeLa cells with more than five pRPA or BrdU foci after Plk3 siRNA or Plki and irradiation with 2 Gy  particles. (c) Phosphorylation of CtIP by Plk3 in vitro. 
Various GFP-CtIP proteins obtained by IP from transfected HeLa cells were incubated in vitro with Plk3. Phosphorylation was measured by 32P incorporation 
and normalized to cells transfected with CtIP-wt. The signal was strongly diminished in CtIP constructs rendered unphosphorylatable at S327 and T847 
(CtIP-S327E/T847E) but normal in CtIP constructs rendered unphosphorylatable at the ATM-dependent sites S664 and S745 (CtIP-S664E/S745E). The re-
sidual signal in the CtIP-S327E/T847E mutants is consistent with the presence of additional Cdk phosphorylation sites on CtIP. The CtIP-4×E mutant (CtIP-
S664E/S745E/S327E/T847E) shows a signal similar to CtIP-S327E/T847E. Equal CtIP loading was controlled by Western blotting. (d) GFP-CtIP or S 
protein–CtIP obtained by IP from siRNA-treated and -transfected HEK293T cells was incubated in vitro with Plk3 and analyzed with a CtIP-pS327, a CtIP-
pT847, or a phosphoserine-specific antibody. S protein–CtIP with and without Plk3 incubation was also analyzed by mass spectrometry (see also Table 1; 
±SEM from at least three experiments). siCtrl, control siRNA; siPlk1, Plk1 siRNA; siPlk3, Plk3 siRNA. *, P < 0.05; ***, P < 0.001.
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Figure S4.  Plk3 phosphorylates CtIP in vivo. (a) HEK293T cells were treated with CtIP and Plk3_11 siRNAs, transfected with GFP-CtIP plasmids, enriched 
in G1 (≥90%), and irradiated with 5 Gy. GFP-CtIP was obtained by IP and analyzed for pS327 at 30 min after IR or pT847 at 2 h after IR by immunoblot-
ting. (b) Confluent 82-6 fibroblasts were treated with Plki and irradiated with 5 Gy. Endogenous CtIP was obtained by IP and analyzed for pS327 at 30 
min after IR or pT847 at 2 h after IR by immunoblotting. (c) Confluent 82-6 fibroblasts were treated with ATMi and harvested at 30 min after 20 Gy. Cell ly-
sates were incubated for 30 min at 30°C with or without -phosphatase and analyzed for Plk3 by immunoblotting. (d) HEK293T cells were treated with 
CtIP and ATM siRNAs, transfected with GFP-CtIP plasmids, enriched in G1 (≥90%), and irradiated with 5 Gy. GFP-CtIP was obtained by IP and analyzed 
for pS327 at 30 min after IR or pT847 at 2 h after IR by immunoblotting. (e) Fraction of GFP-positive (GFP+), G1-phase HeLa cells with more than five pRPA 
foci after 2 Gy -particle irradiation. Cells were treated with CtIP and Plk3 siRNAs and transfected with GFP-CtIP plasmids. Transfection efficiencies were 
confirmed by Western blotting and immunofluorescence (±SEM from three experiments). siCtrl, control siRNA; siCtIP, CtIP siRNA; siATM, ATM siRNA; 
siPlk3, Plk3 siRNA. ***, P < 0.001.
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Figure S5.  Plk3 promotes CtIP function in G1. (a) Interaction of Plk3-PBD with CtIP-S327A and CtIP-T847A in unirradiated cells. HEK293T cells were 
treated with CtIP and Plk3 siRNAs and transfected with GFP-CtIP and SFB-Plk3 plasmids. Plk3 was obtained by IP, and precipitates were analyzed by immu-
noblotting. (b) Translocations in G1- and G2-phase 82-6 fibroblasts after Plk3 siRNA or Plki. The data for G1 were taken from Fig. 7 c. (c, left) Analysis of 
excision events in GC92 cells. Cells were treated with Plk3 siRNAs or Plki, and excisions were measured by the fraction of cells that exhibited a CD4-posi-
tive signal relative to all cells. Knockdown efficiencies for Plk3 siRNAs were confirmed by Western blotting. (right) Analysis of gene conversion events in 
HeLa pGC cells carrying an integrated GFP reporter system. Cells were treated with Plk3 siRNAs or Plki, and gene conversions were measured by the frac-
tion of cells that exhibited a GFP-positive signal relative to all cells. Results were normalized to cells treated with control siRNA. (d) -H2AX foci in G2-phase 
wt and Ku80/ MEFs treated with CtIP siRNA and/or Plki and PARP inhibitor (PARPi). (e) Model for CtIP phosphorylation by Plk3 (see the second to last 
paragraph of the Discussion for explanation). Error bars show ±SEM. siCtrl, control siRNA; siCtIP, CtIP siRNA; siPlk3, Plk3 siRNA. *, P < 0.05; **, P < 
0.01; ***, P < 0.001.
